バルーンカテーテルの世界市場：洞察、競合情勢、市場予測：2032年

バルーンカテーテルの市場規模は、2024年に49億7,201万米ドルとなりました。同市場は、2025年から2032年までの予測期間中にCAGR 7.63%で成長し、2032年には89億2,876万米ドルに達すると予測されています。心血管疾患、脳動脈瘤、骨盤領域のがんの有病率が上昇していることが、バルーンカテーテル市場を大きく押し上げています。心血管系疾患が一般的になるにつれ、バルーンカテーテルの需要も増加しています。また、バルーンカテーテルは脳動脈瘤の管理や骨盤内がんのドラッグデリバリー強化にも不可欠です。同時に、主要市場参入企業による製品開拓の進展により、薬剤溶出性バルーンや生体吸収性バルーンなどの革新的技術が生み出されています。このような複合的要因がバルーンカテーテル市場を牽引しており、ヘルスケアプロバイダーは多様化する患者人口の臨床ニーズに対応するための効果的なソリューションを模索しています。これらの要因が相まって、2025年から2032年までの予測期間中、バルーンカテーテル市場は拡大すると予想されます。

バルーンカテーテル市場力学：

英国心臓財団（British Heart Foundation）の最新データ（2025年）によると、全世界の推定患者数は6億4,000万人で、約12人に1人が心臓・循環器疾患を抱えています。英国心臓財団（2024年）のさらなるデータによると、冠動脈（虚血性）心疾患は世界的に最も一般的に診断される心血管系疾患であり、男性約1億1,000万人、女性8,000万人を含む約2億人が罹患しています。さらに、脳卒中生存者は世界で女性約5,600万人、男性約4,500万人でした。さらに、少なくとも1,300万人が先天性心疾患を抱えており、数100万人が未診断のままである可能性があります。

冠動脈疾患、末梢動脈疾患、脳卒中などの心血管系疾患の世界の有病率の上昇は、効果的で低侵襲な介入に対する需要を促進しています。そのような介入の一つが経皮経管冠動脈形成術（PTCA）であり、バルーン・カテーテルを用いて狭窄または閉塞した動脈を開いて血流を回復させ、心臓発作や脳卒中のリスクを低減します。心血管系疾患の負担が増え続ける中、PTCAやPCI処置の件数は増加すると予想され、PTCAバルーンカテーテルの需要を直接的に高め、市場の拡大を後押ししています。

バルーンカテーテルは心血管用途以外にも、がん関連合併症の管理にも重要な役割を果たしています。GLOBOCAN（2022年）によると、腎臓がんの新規患者数は世界で約43万5,000人、2045年までに69万3,000人に増加すると予測されています。同様に、膀胱がんの新規症例は2022年には61万4,000人と推定され、2045年には112万人に達すると予測されています。骨盤内のがんは尿管を閉塞させ、腎臓から膀胱への尿の流れを悪くします。その結果、尿がたまり、腎臓が損傷する可能性があります。このような場合、腎瘻造設術が行われ、多くの場合、腎瘻バルーンカテーテルを用いて尿排出用の通路を作る必要があります。骨盤内がんの罹患率が上昇するにつれ、バルーンカテーテルに対する需要は増加し、世界のバルーンカテーテル市場の成長にさらに貢献すると予想されます。

さらに、継続的な製品革新と規制当局の承認が市場の勢いを後押ししています。例えば、Teleflex Incorporatedは2024年7月、市販されている唯一のPTCA灌流バルーンカテーテルであるリンガー（TM）灌流バルーンカテーテル（PBC）のFDA 510（k）認可を取得しました。このバルーンカテーテルは、急速交換デザインと、バルーンを膨らませると中空円筒状になるヘリカルバルーンを特徴としており、長時間のバルーン拡張でも冠動脈血流を持続させることができ、遠位灌流が必要な冠動脈やバイパスグラフトの狭窄部の拡張に使用されます。

しかし、市場には課題もあります。動脈解離、血管穿孔、塞栓症といったバルーンカテーテル手技に伴うリスクは、深刻な合併症につながる可能性があります。さらに、品質や安全性の問題に起因する製品回収の増加が、今後の市場成長を妨げる可能性もあります。

世界のバルーンカテーテル市場は、心血管疾患やがんの増加、技術革新の進展により大きく成長する見込みですが、長期的な市場拡大を維持するには、機器の安全性と品質に関する継続的な警戒が不可欠です。

バルーンカテーテル市場セグメント分析：

バルーンカテーテル市場のバルーンタイプ別では、ノンコンプライアントバルーンカテーテルカテゴリーが2024年に最大シェアを占める見込みです。ノンコンプライアント型バルーンは形状とサイズを維持するため、狭窄または閉塞した血管の拡張をより予測しやすく制御できます。この特性により、冠動脈疾患の治療など、周囲組織を損傷することなく最適な結果を得るには正確なバルーンサイズ設定が重要となる高圧用途で、バルーンが特に威力を発揮します。ノンコンプライアント型バルーンの優れた性能は、血管形成術のような手技において、バルーンの破裂や血管の外傷といった合併症のリスクを低減し、より良い結果をもたらします。このような特殊なバルーンカテーテルの有用性がヘルスケアプロバイダーによって認識されるにつれ、ノンコンプライアントバルーンカテーテルの需要は拡大しています。

また、材料技術や設計の進歩により、ノンコンプライアントバルーンはより効果的で汎用性の高いものとなり、さまざまな医療分野での採用が進んでいます。こうしたノンコンプライアントバルーンカテーテルへのシフトは、手技の成功率を高めるだけでなく、バルーンカテーテル市場全体の拡大も後押ししています。例えば、2023年9月、Kossel MedtechのSabelly（R）ノンコンプライアント末梢バルーン拡張カテーテルが中国のNMPAから市場承認を取得しました。末梢血管形成術用に設計されたこのカテーテルは、承認された初の国産大口径バルーンカテーテルとなり、輸入製品への依存度を下げる一助となっています。

以上のことから、予測期間中、バルーンカテーテルの世界市場全体の成長を牽引する同分野の収益が大幅に増加すると予想されます。

バルーンカテーテル市場全体では北米が優位を占めると予想される：

全地域の中で、北米が2024年のバルーンカテーテル世界市場で最大のシェアを占めると予想されています。バルーンカテーテル市場の主な促進要因は、脳動脈瘤、膀胱がん、前立腺肥大症、尿閉などの泌尿器科疾患、さまざまな心血管疾患の開発につながる生活習慣病の有病率の上昇、および同地域における製品開発活動への注目の高まりです。これらの要因が相まって、同地域のバルーンカテーテル市場全体が拡大すると予想されています。

米国心臓協会が発表したデータ（2023年）によると、米国では年間50万件以上の経皮的冠動脈インターベンションが実施されており、そのうち経皮経管冠動脈形成術が大きなシェアを占めています。このため、心血管障害の有病率の上昇とそれに伴うPCI施行件数の増加が、スコアリング・カッティング用バルーンカテーテルの需要をさらに押し上げると予想されます。これが北米におけるバルーンカテーテル市場の成長に寄与していると推定されます。

北米におけるバルーンカテーテル市場の成長には、脳動脈瘤の有病率の上昇も寄与しています。脳動脈瘤財団の統計（2023年）によると、同国では毎年約3万人が脳動脈瘤の破裂に苦しんでいます。米国がん協会が提供する別のデータでは、2023年、米国では脳または脊髄の悪性腫瘍が約2万4,350個発生すると推定されています。また、2023年には国内で約1万8,600人が脳腫瘍や脊髄腫瘍で死亡すると推定されています。これらの適応症は通常、神経血管系への投与用に特別に考案された閉塞バルーンカテーテルで治療されます。このため、脳動脈瘤の有病率の上昇もバルーンカテーテルの需要を押し上げ、北米のバルーンカテーテル市場の成長を後押しすると予想されます。

さらに、同地域全体での製品開拓活動も、同地域のバルーンカテーテル市場全体を押し上げると予想されます。例えば、2023年8月、Shanghai MicroPort Medical（MicroPort（R）Coronary）は、Firefighter（TM）NC Pro PTCAバルーンカテーテルのFDA承認を取得しました。この次世代高圧バルーンは、狭窄冠動脈の拡張およびステント留置後の処置用に設計されました。3層構造の複合バルーンと最大22気圧の破裂圧により、石灰化のような抵抗性病変を効果的に治療することができます。

このため、同地域では上記のような要因が予測期間中の北米バルーンカテーテル市場を押し上げると予想されます。

バルーンカテーテル市場の主要企業

バルーンカテーテル市場で事業を展開する主要企業には、Medtronic、Boston Scientific Corporation、Abbott、Cook、B. Braun Melsungen AG、Cardinal Health、Terumo Corporation、Stryker、Teleflex Incorporated、Microport Scientific Corporation、BIOTRONIK、Nipro Medical Corporation、BD、Coloplast、Summit Medical（Innovia Medical）Well Lead Medical Co., Ltd.、Smiths Medical、BACTIGUARD AB、JOTEC GmbH、Lepu Medical Technology（Beijing）Co., Ltd.などがあります。

バルーンカテーテル市場における最近の開発動向：

• 2024年3月、Boston Scientific Corporationは、冠動脈疾患患者の冠動脈ステント内再狭窄（ISR）治療に適応のあるAGENT（TM）Drug-Coated Balloon（DCB）カテーテルのFDA承認を発表しました。
• 2022年5月、Medtronicは米国食品医薬品局（FDA）から、大腿表在動脈および膝窩動脈の末梢動脈疾患（PAD）のインターベンション治療を適応とする薬剤被覆バルーン（DCB）IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty（PTA）バルーンカテーテルの承認を取得したと発表しました。

バルーンカテーテル市場調査報告書の主な内容

• 現在のバルーンカテーテルの市場規模分析（2024年）、および8年間（2025年から2032年）の市場予測
• 過去3年間に起こった主な製品/技術開発、合併、買収、提携、合弁事業
• バルーンカテーテル市場を独占する主要企業
• バルーンカテーテル市場における競合他社のビジネスチャンス
• 2024年に上位を占めるセグメントと2030年におけるこれらのセグメントの業績
• 現在のバルーンカテーテル市場シナリオで上位を占める地域・国
• 今後バルーンカテーテル市場の成長機会に企業が注力すべき地域・国

バルーンカテーテル市場に関するよくある質問

1.バルーンカテーテル

• バルーンカテーテルとは、カテーテルの先端にバルーンを取り付けた軟性カテーテルの一種です。このタイプのカテーテルは、閉塞部の開通、血管の拡張、ステント留置など、様々な低侵襲診断・治療処置に使用されます。

2.バルーンカテーテル市場

• バルーンカテーテル市場は、2024年に49億7,201万米ドルと評価され、2025年から2032年までの予測期間中にCAGR 7.63%で成長し、2032年には89億2,876万米ドルに達します。

3.バルーンカテーテル市場の促進要因

• 心血管疾患、脳動脈瘤、骨盤領域のがんの有病率の上昇が、バルーンカテーテル市場を大きく押し上げています。心血管系疾患が一般的になるにつれ、バルーンカテーテルの需要が増加しています。また、バルーンカテーテルは脳動脈瘤の管理や骨盤内がんのドラッグデリバリー強化にも不可欠です。同時に、主要市場参入企業別製品開拓の進展により、薬剤溶出性バルーンや生体吸収性バルーンなどの革新的技術が生み出されています。このような複合的要因がバルーンカテーテル市場を牽引しており、ヘルスケアプロバイダーは多様化する患者人口の臨床ニーズに対応するための効果的なソリューションを模索しています。これらの要因が相まって、2025年から2032年までの予測期間中、バルーンカテーテル市場は拡大すると予想されます。

4.バルーンカテーテル市場の主な参入企業は

• バルーンカテーテル市場で事業を展開する主要企業には、Medtronic、Boston Scientific Corporation、Abbott、Cook、B. Braun Melsungen AG、Cardinal Health、Terumo Corporation、Stryker、Teleflex Incorporated、Microport Scientific Corporation、BIOTRONIK、Nipro Medical Corporation、BD、Coloplast、Summit Medical（Innovia Medical）Well Lead Medical Co., Ltd.、Smiths Medical、BACTIGUARD AB、JOTEC GmbH、Lepu Medical Technology（Beijing）Co., Ltd.などがあります。

5.バルーンカテーテル市場で最もシェアが高い地域

• 全地域の中で、北米が2024年のバルーンカテーテル世界市場で最大のシェアを占めると予想されています。バルーンカテーテル市場の主な促進要因は、脳動脈瘤、膀胱がん、前立腺肥大症、尿閉などの泌尿器科疾患、さまざまな心血管疾患の開発につながる生活習慣病の有病率の上昇、および同地域における製品開発活動への注目の高まりです。これらの要因が相まって、同地域のバルーンカテーテル市場全体が拡大すると予想されます。

目次

第1章 バルーンカテーテル市場レポートのイントロダクション

第2章 バルーンカテーテル市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 バルーンカテーテル市場の主な要因分析

• バルーンカテーテル市場促進要因
  • 心血管疾患の有病率の上昇
  • 脳動脈瘤の罹患率の上昇
  • 骨盤領域のがんの罹患率の上昇
  • 世界中の主要な市場参入企業による製品開発活動の増加
• バルーンカテーテル市場抑制要因と課題
  • バルーンカテーテルに伴う外科的リスク
  • 製品リコールの増加
• バルーンカテーテル市場の機会
  • バルーンカテーテルの安全性の見通しと設計上の欠陥の継続的な改善

第6章 バルーンカテーテル市場：ポーターのファイブフォース分析

第7章 バルーンカテーテル市場の評価

• 製品タイプ別
  • PTAバルーンカテーテル
  • PTCAバルーンカテーテル
  • 閉塞バルーンカテーテル
  • フォーリーカテーテル
  • 腎瘻バルーンカテーテル
  • 薬剤溶出カテーテル
  • その他
• カテーテルタイプ別
  • 固定ワイヤー
  • OTW
  • ラピッド・エクスチェンジ
• バルーンタイプ別
  • ノンコンプライアント
  • セミコンプライアント
  • コンプライアント
• エンドユーザー別
  • 病院
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 バルーンカテーテル市場の企業と製品プロファイル

• Medtronic
• Boston Scientific Corporation
• Abbott
• Cook
• B. Braun Melsungen AG
• Cardinal Health
• Terumo Corporation
• Stryker
• Teleflex Incorporated
• Microport Scientific Corporation
• BIOTRONIK
• Nipro Medical Corporation
• BD
• Coloplast
• Summit Medical (Innovia Medical)
• Well Lead Medical Co., Ltd.
• Smiths Medical
• BACTIGUARD AB
• JOTEC GmbH
• Lepu Medical Technology(Beijing)Co.,Ltd.

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Balloon Catheters Market in Global (2022-2032)
• Table 3: Balloon Catheters Market in Global by Product Type (2022-2032)
• Table 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
• Table 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
• Table 6: Balloon Catheters Market in Global by End-User (2022-2032)
• Table 7: Balloon Catheters Market in Global by Geography (2022-2032)
• Table 8: Balloon Catheters Market in North America (2022-2032)
• Table 9: Balloon Catheters Market in the United States (2022-2032)
• Table 10: Balloon Catheters Market in Canada (2022-2032)
• Table 11: Balloon Catheters Market in Mexico (2022-2032)
• Table 12: Balloon Catheters Market in Europe (2022-2032)
• Table 13: Balloon Catheters Market in France (2022-2032)
• Table 14: Balloon Catheters Market in Germany (2022-2032)
• Table 15: Balloon Catheters Market in United Kingdom (2022-2032)
• Table 16: Balloon Catheters Market in Italy (2022-2032)
• Table 17: Balloon Catheters Market in Spain (2022-2032)
• Table 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
• Table 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
• Table 20: Balloon Catheters Market in China (2022-2032)
• Table 21: Balloon Catheters Market in Japan (2022-2032)
• Table 22: Balloon Catheters Market in India (2022-2032)
• Table 23: Balloon Catheters Market in Australia (2022-2032)
• Table 24: Balloon Catheters Market in South Korea (2022-2032)
• Table 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
• Table 26: Balloon Catheters Market in the Rest of the World (2022-2032)
• Table 27: Balloon Catheters Market in the Middle East (2022-2032)
• Table 28: Balloon Catheters Market in Africa (2022-2032)
• Table 29: Balloon Catheters Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Balloon Catheters Market in Global (2022-2032)
• Figure 3: Balloon Catheters Market in Global by Product Type (2022-2032)
• Figure 4: Balloon Catheters Market in Global by Catheter Type (2022-2032)
• Figure 5: Balloon Catheters Market in Global by Balloon Type (2022-2032)
• Figure 6: Balloon Catheters Market in Global by End-User (2022-2032)
• Figure 7: Balloon Catheters Market in Global by Geography (2022-2032)
• Figure 8: Balloon Catheters Market in North America (2022-2032)
• Figure 9: Balloon Catheters Market in the United States (2022-2032)
• Figure 10: Balloon Catheters Market in Canada (2022-2032)
• Figure 11: Balloon Catheters Market in Mexico (2022-2032)
• Figure 12: Balloon Catheters Market in Europe (2022-2032)
• Figure 13: Balloon Catheters Market in France (2022-2032)
• Figure 14: Balloon Catheters Market in Germany (2022-2032)
• Figure 15: Balloon Catheters Market in United Kingdom (2022-2032)
• Figure 16: Balloon Catheters Market in Italy (2022-2032)
• Figure 17: Balloon Catheters Market in Spain (2022-2032)
• Figure 18: Balloon Catheters Market in the Rest of Europe (2022-2032)
• Figure 19: Balloon Catheters Market in Asia-Pacific (2022-2032)
• Figure 20: Balloon Catheters Market in China (2022-2032)
• Figure 21: Balloon Catheters Market in Japan (2022-2032)
• Figure 22: Balloon Catheters Market in India (2022-2032)
• Figure 23: Balloon Catheters Market in Australia (2022-2032)
• Figure 24: Balloon Catheters Market in South Korea (2022-2032)
• Figure 25: Balloon Catheters Market in Rest of Asia-Pacific (2022-2032)
• Figure 26: Balloon Catheters Market in the Rest of the World (2022-2032)
• Figure 27: Balloon Catheters Market in the Middle East (2022-2032)
• Figure 28: Balloon Catheters Market in Africa (2022-2032)
• Figure 29: Balloon Catheters Market in South America (2022-2032)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Market Opportunities
• Figure 33: PORTER'S Five Force Analysis

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of cardiovascular diseases, growing prevalence of brain aneurysms, increasing prevalence of cancers in the pelvic region, and increase in product development activities by key market players across the globe.

The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032. The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

Balloon Catheters Market Dynamics:

According to recent data from the British Heart Foundation (2025), an estimated 640 million people worldwide approximately 1 in 12 individuals were living with heart and circulatory diseases. Further data from the British Heart Foundation (2024) highlighted that coronary (ischemic) heart disease was the most commonly diagnosed cardiovascular condition globally, affecting around 200 million people, including approximately 110 million men and 80 million women. Additionally, there were about 56 million female and 45 million male stroke survivors globally. Moreover, at least 13 million individuals lived with congenital heart disease, with millions potentially remaining undiagnosed.

The increasing global prevalence of cardiovascular disorders such as coronary artery disease, peripheral artery disease, and strokes is driving demand for effective, minimally invasive interventions. One such intervention is percutaneous transluminal coronary angioplasty (PTCA), which uses balloon catheters to open narrowed or blocked arteries and restore blood flow, thereby reducing the risk of heart attacks and strokes. As the burden of cardiovascular disease continues to rise, the number of PTCA and PCI procedures is expected to grow, directly fueling the demand for PTCA balloon catheters and supporting market expansion.

Beyond cardiovascular applications, balloon catheters also play a critical role in managing cancer-related complications. According to GLOBOCAN (2022), there were approximately 435,000 new cases of kidney cancer globally, a number projected to rise to 693,000 by 2045. Similarly, new bladder cancer cases were estimated at 614,000 in 2022, with projections reaching 1.12 million by 2045. Cancers in the pelvic region can obstruct the ureters, impairing urine flow from the kidneys to the bladder. This leads to a buildup of urine and potential kidney damage. In such cases, nephrostomy procedures are performed, often requiring nephrostomy balloon catheters to create a passage for urine drainage. As the incidence of pelvic cancers rises, the demand for these devices is expected to increase, contributing further to the growth of the global balloon catheter market.

Additionally, ongoing product innovation and regulatory approvals are boosting market momentum. For example, in July 2024, Teleflex Incorporated received FDA 510(k) clearance for its Ringer(TM) Perfusion Balloon Catheter (PBC) the only commercially available PTCA perfusion balloon catheter. Featuring a rapid-exchange design and helical balloon that forms a hollow cylinder when inflated, the device allows continuous coronary blood flow during prolonged inflations and is used for dilating coronary arteries or bypass graft stenoses where distal perfusion is necessary.

However, the market does face challenges. Risks associated with balloon catheter procedures such as arterial dissection, vessel perforation, or embolism can lead to serious complications. Moreover, increasing product recalls due to quality and safety issues may hinder future market growth.

In summary, while the global balloon catheters market is poised for significant growth due to rising cardiovascular and cancer cases and increasing innovation, ongoing vigilance regarding device safety and quality remains critical to sustaining long-term market expansion.

Balloon Catheters Market Segment Analysis:

Balloon Catheters Market by Product Type (PTA, PTCA, Occlusion, Foley, Nephrostomy, Drug-Eluting, and Others), Catheter Type (Fixed Wire, Over-The-Wire, and Rapid Exchange), Balloon Type (Non-Compliant, Semi-Compliant, and Compliant), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the balloon type segment of the balloon catheters market, the non-compliant balloon catheter category is expected to hold the largest share in the year 2024. Non-compliant balloons maintain their shape and size, providing a more predictable and controlled dilation of narrowed or obstructed vessels. This characteristic makes them particularly valuable in high-pressure applications, such as in the treatment of coronary artery disease, where precise balloon sizing is critical in achieving optimal results without damaging the surrounding tissue. The enhanced performance of non-compliant balloons leads to better outcomes in procedures like angioplasty, reducing the risk of complications such as balloon rupture or vessel trauma. As healthcare providers increasingly recognize the benefits of these specialized devices, the demand for non-compliant balloon catheters has grown.

Additionally, advancements in material technology and design are making non-compliant balloons more effective and versatile, further driving their adoption across various medical fields. This shift towards non-compliant balloon catheters not only enhances procedural success rates but also supports the expansion of the balloon catheter market as a whole. For instance, in September 2023, Kossel Medtech's Sabelly(R) non-compliant peripheral balloon dilatation catheter received market approval from China's NMPA. Designed for angioplasty in the peripheral vascular system, it became the first domestically produced large-diameter balloon catheter approved, helping to reduce reliance on imported products.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global balloon catheters market during the forecast period.

North America is expected to dominate the overall balloon catheter market:

Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

As per the data stated by the American Heart Association (2023), over 500,000 percutaneous coronary interventions were performed in the United States annually of which percutaneous transluminal coronary angioplasty holds a considerable share. Therefore, the rising prevalence of cardiovascular disorders as well as the subsequent increase in the number of PCI procedures being performed are further expected to boost the demand for scoring and cutting balloon catheters. This is estimated to contribute to the regional growth of the balloon catheters market in North America.

Another factor contributing to the regional growth of the North America balloon catheters market is the rising prevalence of brain aneurysms in the country. As per the statistics provided by the Brain Aneurysm Foundation (2023), approximately 30,000 people in the country suffer from a brain aneurysm rupture each year. In another set of data provided by the American Cancer Society, in 2023, it has been estimated that approximately 24,350 malignant tumors of the brain or spinal cord may occur in the US. It also estimated that in 2023, approximately 18,600 people were expected to succumb to brain and spinal cord tumors in the country. These indications are usually treated with occlusion balloon catheters specially devised for the administration in the neurovasculature. Therefore, the rising prevalence of brain aneurysms is also expected to drive the demand for such catheters, eventually boosting the growth of the market for balloon catheters in North America.

Additionally, product development activities across the region are further expected to boost the overall market of balloon catheters across the region. For instance, in August 2023, Shanghai MicroPort Medical (MicroPort(R) Coronary) received FDA approval for its Firefighter(TM) NC Pro PTCA Balloon Catheter. This next-generation high-pressure balloon was designed for dilating narrowed coronary arteries and post-stent procedures. With a three-layer composite balloon and a burst pressure of up to 22 atm, it effectively treated resistant lesions like calcifications.

Therefore, the factors mentioned above in the region are expected to boost the North America balloon catheters market during the forecast period.

Balloon Catheters Market Key Players:

Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

Recent Developmental Activities in the Balloon Catheters Market:

• In March 2024, Boston Scientific Corporation announced the approval of the FDA for the AGENT(TM) Drug-Coated Balloon (DCB) catheter, which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.
• In May 2022, Medtronic announced the approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.

Key takeaways from the balloon catheters market report study:

• Market size analysis for current balloon catheters size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the balloon catheters market.
• Various opportunities available for the other competitors in the balloon catheters market space.
• What are the top-performing segments in 2024? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current balloon catheter market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for balloon catheter market growth in the coming future?

Target audience who can benefit from this balloon catheter market report study:

• Balloon catheter product providers
• Research organizations and consulting companies
• Balloon catheters-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in balloon catheters
• Various end-users who want to know more about the balloon catheters market and the latest technological developments in the balloon catheters market.

Frequently Asked Questions for the Balloon Catheters Market:

1. What are balloon catheters?

• A balloon catheter is a type of soft catheter that has a balloon attached at the tip of the catheter. This type of catheter is used in various minimally invasive diagnostic and therapeutic procedures such as opening of blockages, dilating vessels, and stent delivery among others.

2. What is the market for balloon catheters?

• The balloon catheters market was valued at USD 4,972.01 million in 2024, growing at a CAGR of 7.63% during the forecast period from 2025 to 2032, to reach USD 8,928.76 million by 2032.

3. What are the drivers for the balloon catheter market?

• The rising prevalence of cardiovascular diseases, brain aneurysms, and pelvic region cancers is significantly boosting the market for balloon catheters. As cardiovascular conditions become more common, the demand for balloon catheters increases. Additionally, balloon catheters are vital in managing brain aneurysms and enhancing drug delivery in pelvic cancers. Concurrently, advancements in product development by key market players are leading to innovative technologies, such as drug-eluting and bioresorbable balloons. These combined factors are driving the balloon catheter market as healthcare providers seek effective solutions to address the growing clinical needs of diverse patient populations. Collectively, these factors are expected to boost the market for balloon catheters during the forecast period from 2025 to 2032.

4. Who are the key players operating in the balloon catheters market?

• Some of the key market players operating in the balloon catheters market include Medtronic, Boston Scientific Corporation, Abbott, Cook, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, Stryker, Teleflex Incorporated, Microport Scientific Corporation, BIOTRONIK, Nipro Medical Corporation, BD, Coloplast, Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd., Smiths Medical, BACTIGUARD AB, JOTEC GmbH, Lepu Medical Technology(Beijing)Co., Ltd., and others.

5. Which region has the highest share in the balloon catheters market?

• Among all the regions, North America is expected to hold the largest share of the global balloon catheters market in 2024. The key driving factors of the balloon catheters market are the increasing prevalence of brain aneurysms, urological disorders such as bladder cancers, benign prostatic hyperplasia, urinary retention, increasing prevalence of lifestyle disorders leading to the development of various cardiovascular diseases as well as growing focus on product development activities in the region. Collectively, these factors are expected to boost the overall market of balloon catheters across the region.

Table of Contents

1. Balloon Catheters Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Balloon Catheters Market Executive Summary

• 2.1 Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1 The United States
• 4.2 Europe
• 4.3 Japan
• 4.4 China

5. Balloon Catheters Market Key Factors Analysis

• 5.1. Balloon Catheters Market Drivers
  • 5.1.1 Rising prevalence of cardiovascular diseases
  • 5.1.2 Growing prevalence of brain aneurysms
  • 5.1.3 Increasing prevalence of cancers in the pelvic region
  • 5.1.4 Increase in product development activities by key market players across the globe.
• 5.2 Balloon Catheters Market Restraints and Challenges
  • 5.2.1 Surgical risk associated with balloon catheters
  • 5.2.2 The increased number of product recalls
• 5.3 Balloon Catheters Market Opportunities
  • 5.3.1 Ongoing improvement in safety prospects and design-related shortcomings in balloon catheters

6. Balloon Catheters Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Balloon Catheters Market Assessment

• 7.1 By Product Type
  • 7.1.1 PTA Balloon Catheters
  • 7.1.2 PTCA Balloon Catheters
  • 7.1.3 Occlusion Balloon Catheters
  • 7.1.4 Foley Catheters
  • 7.1.5 Nephrostomy Balloon Catheters
  • 7.1.6 Drug-Eluting Catheters
  • 7.1.7 Others
• 7.2 By Catheter Type
  • 7.2.1 Fixed Wire
  • 7.2.2 Over-the-Wire
  • 7.2.3 Rapid Exchange
• 7.3 By Balloon Type
  • 7.3.1 Non-Compliant
  • 7.3.2 Semi-Compliant
  • 7.3.3 Compliant
• 7.4 By End-User
  • 7.4.1 Hospitals
  • 7.4.2 Specialty Clinics
• 7.5 By Geography
  • 7.5.1 North America
    • 7.5.1.1 United States Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.1.2 Canada Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.1.3 Mexico Balloon Catheters Market Size in USD Million (2022-2032)
  • 7.5.2 Europe
    • 7.5.2.1 France Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2.2 Germany Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2.3 United Kingdom Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2.4 Italy Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2.5 Spain Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.2.6 Rest of Europe Balloon Catheters Market Size in USD Million (2022-2032)
  • 7.5.3 Asia-Pacific
    • 7.5.3.1 China Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3.2 Japan Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3.3 India Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3.4 Australia Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3.5 South Korea Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.3.6 Rest of Asia-Pacific Balloon Catheters Market Size in USD Million (2022-2032)
  • 7.5.4 Rest of the World (RoW)
    • 7.5.4.1 Middle East Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.4.2 Africa Balloon Catheters Market Size in USD Million (2022-2032)
    • 7.5.4.3 South America Balloon Catheters Market Size in USD Million (2022-2032)

8. Balloon Catheters Market Company and Product Profiles

• 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Company Snapshot
  • 8.1.3 Financial Overview
  • 8.1.4 Product Listing
  • 8.1.5 Entropy
• 8.2 Boston Scientific Corporation
  • 8.2.1 Company Overview
  • 8.2.2 Company Snapshot
  • 8.2.3 Financial Overview
  • 8.2.4 Product Listing
  • 8.2.5 Entropy
• 8.3 Abbott
  • 8.3.1 Company Overview
  • 8.3.2 Company Snapshot
  • 8.3.3 Financial Overview
  • 8.3.4 Product Listing
  • 8.3.5 Entropy
• 8.4 Cook
  • 8.4.1 Company Overview
  • 8.4.2 Company Snapshot
  • 8.4.3 Financial Overview
  • 8.4.4 Product Listing
  • 8.4.5 Entropy
• 8.5 B. Braun Melsungen AG
  • 8.5.1 Company Overview
  • 8.5.2 Company Snapshot
  • 8.5.3 Financial Overview
  • 8.5.4 Product Listing
  • 8.5.5 Entropy
• 8.6 Cardinal Health
  • 8.6.1 Company Overview
  • 8.6.2 Company Snapshot
  • 8.6.3 Financial Overview
  • 8.6.4 Product Listing
  • 8.6.5 Entropy
• 8.7 Terumo Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Company Snapshot
  • 8.7.3 Financial Overview
  • 8.7.4 Product Listing
  • 8.7.5 Entropy
• 8.8 Stryker
  • 8.8.1 Company Overview
  • 8.8.2 Company Snapshot
  • 8.8.3 Financial Overview
  • 8.8.4 Product Listing
  • 8.8.5 Entropy
• 8.9 Teleflex Incorporated
  • 8.9.1 Company Overview
  • 8.9.2 Company Snapshot
  • 8.9.3 Financial Overview
  • 8.9.4 Product Listing
  • 8.9.5 Entropy
• 8.10. Microport Scientific Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Company Snapshot
  • 8.10.3 Financial Overview
  • 8.10.4 Product Listing
  • 8.10.5 Entropy
• 8.11. BIOTRONIK
  • 8.11.1 Company Overview
  • 8.11.2 Company Snapshot
  • 8.11.3 Financial Overview
  • 8.11.4 Product Listing
  • 8.11.5 Entropy
• 8.12. Nipro Medical Corporation
  • 8.12.1 Company Overview
  • 8.12.2 Company Snapshot
  • 8.12.3 Financial Overview
  • 8.12.4 Product Listing
  • 8.12.5 Entropy
• 8.13. BD
  • 8.13.1 Company Overview
  • 8.13.2 Company Snapshot
  • 8.13.3 Financial Overview
  • 8.13.4 Product Listing
  • 8.13.5 Entropy
• 8.14. Coloplast
  • 8.14.1 Company Overview
  • 8.14.2 Company Snapshot
  • 8.14.3 Financial Overview
  • 8.14.4 Product Listing
  • 8.14.5 Entropy
• 8.15. Summit Medical (Innovia Medical)
  • 8.15.1 Company Overview
  • 8.15.2 Company Snapshot
  • 8.15.3 Financial Overview
  • 8.15.4 Product Listing
  • 8.15.5 Entropy
• 8.16. Well Lead Medical Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Company Snapshot
  • 8.16.3 Financial Overview
  • 8.16.4 Product Listing
  • 8.16.5 Entropy
• 8.17. Smiths Medical
  • 8.17.1 Company Overview
  • 8.17.2 Company Snapshot
  • 8.17.3 Financial Overview
  • 8.17.4 Product Listing
  • 8.17.5 Entropy
• 8.18. BACTIGUARD AB
  • 8.18.1 Company Overview
  • 8.18.2 Company Snapshot
  • 8.18.3 Financial Overview
  • 8.18.4 Product Listing
  • 8.18.5 Entropy
• 8.19. JOTEC GmbH
  • 8.19.1 Company Overview
  • 8.19.2 Company Snapshot
  • 8.19.3 Financial Overview
  • 8.19.4 Product Listing
  • 8.19.5 Entropy
• 8.20. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Company Snapshot
  • 8.20.3 Financial Overview
  • 8.20.4 Product Listing
  • 8.20.5 Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us